Spain· ES:99114003
ZEFFIX 5 mg/ml SOLUCION ORAL
A medicinal product containing lamivudina, registered in Spain by Glaxosmithkline Trading Services Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- lamivudina
- Manufacturer
- Glaxosmithkline Trading Services Limited
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lamivudina in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumZeffix 5 mg/mlGlaxoSmithKline
- CzechiaZEFFIXGlaxoSmithKline Trading Services Limited, Dublin
- FinlandZeffixGlaxoSmithKline Trading Services Limited
- FranceZEFFIX 5 mg/ml, solution buvableGLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
- IrelandZeffix 5 mg/ml Oral solutionGlaxoSmithKline Trading Services Limited
- IcelandZeffixGlaxoSmithKline Trading Services Limited
- NetherlandsZeffix 5 mg/ml oplossingGlaxoSmithKline Trading Services Limited
- PolandZeffixGlaxoSmithKline (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Lamivudin Sandoz
- Cyprus · Lamivudine Normon
- Germany · Lamivudin Aurobindo, Lamivudin Mylan
- France · Lamivudine Arrow, Lamivudine Sandoz
- United Kingdom (Northern Ireland) · Lamivudine Amarox, Lamivudine Generics
- Iceland · Epivir, Lamivudine Teva
- Italy · Lamivudina Aurobindo, Lamivudina Aurobindo Italia
- Liechtenstein · Epivir, Lamivudine Teva
- Netherlands · Lamivudine Accord, Lamivudine Aurobindo
- Norway · Epivir, Lamivudine Teva
- Poland · Lamivudine Aurovitas
- Portugal · Lamivudina Aurobindo, Lamivudina Farmoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/220bf799-25f9-4b65-b025-e9fd939146b7 GET /v1/drugs/220bf799-25f9-4b65-b025-e9fd939146b7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":947545200000}",
"nregistro": "99114003",
"substance": "lamivudina"
}See everything about lamivudina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.